Related Experiment Video
Updated: Jun 2, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
Role of microRNAs in lymphoid biology and disease
1Department of Molecular Virology, Immunology and Medical Genetics, the Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210, USA.
Purpose Of Review:
This review provides a state-of-the-art knowledge on the implications of microRNA (miRNA) dysregulation in lymphoid malignancies.
Recent Findings:
Several new studies have broadened our understanding of how aberrations of the miRNome contribute to the development of a malignant lymphoid phenotype. Recently, a new pathogenetic model involving miRNAs and protein coding genes (such as TP53 and ZAP-70) has been identified and explains the prognostic implications of the most recurrent chromosomal abnormalities in human B-cell chronic lymphocytic leukemia. Moreover, new recent studies have addressed the role of miRNAs in human lymphomas and acute lymphoblastic leukemias.
Summary:
The recent advances in our understanding of the role of miRNAs in lymphoid malignancies demonstrate that miRNAs can effectively be used as tumoral biomarkers with implications for diagnosis, prognosis, and prediction of response to therapy.
Insights
MicroRNA (miRNA) dysregulation is implicated in lymphoid malignancies. These findings highlight miRNAs as crucial biomarkers for diagnosing, predicting prognosis, and guiding therapy in these cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression.
- Dysregulation of miRNAs is increasingly recognized in various cancers, including lymphoid malignancies.
Purpose of the Study:
- To provide a comprehensive overview of the role of miRNA dysregulation in lymphoid malignancies.
- To summarize recent advances in understanding miRNA involvement in these diseases.
Main Methods:
- This review synthesizes findings from recent scientific literature.
- It focuses on studies investigating miRNA aberrations and their pathogenetic implications.
Main Results:
- Aberrations in the miRNome contribute to the development of malignant lymphoid phenotypes.
- A new pathogenetic model involving miRNAs and genes like TP53 and ZAP-70 explains prognostic implications in B-cell chronic lymphocytic leukemia.
- Recent studies have elucidated the role of miRNAs in lymphomas and acute lymphoblastic leukemias.
Conclusions:
- MicroRNAs show significant potential as biomarkers for lymphoid malignancies.
- These biomarkers have implications for diagnosis, prognosis, and predicting treatment response.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
